As per attachment.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Iqubal Patel has resigned from the post of Chief Financial Officer and Key Managerial Personnel of Norris Medicines Ltd, effective from the close of business hours on February 3, 2026, citing personal reasons. He held the combined role of Accountant and CFO since January 2022. The company has confirmed it is in the process of appointing a new CFO and will inform the stock exchange in due course. The intimation was filed under SEBI LODR Regulation 30 and signed by Director Vimal D. Shah.
This is a routine key managerial personnel change due to personal reasons with no stated governance concerns. Investors should watch for the announcement of a new CFO appointment, as a prolonged vacancy in this critical finance role could temporarily affect financial reporting oversight.